ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/02/2026
Back to search
Official data from USPTO
NOVO NORDISK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079290058Class
1, 5, 9, 10, 41, 42, 44
Filing
79290058
Registration
6317854
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
07/02/2026
Trademark type
Combined
Nice classes
1, 5, 9, 10, 41, 42, 44
Filing date
04/03/2020
Registration date
04/13/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/13/2021
Last transaction
07/02/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
98
Owner location
DK
Examiner
EVANKO, PATRICIA MALESARDI
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "NOVO NORDISK" below a design of a bull with a circle above its head, all in the color blue.
Holders and representatives
Holders
Novo Nordisk A/S
Representatives
Alexander Reid White & Case LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical preparations for use in industry; chemical additives for use in the manufacture of pharmaceuticalscosmeticshair lotionsdisinfectants; chemical diagnostic reagents for industrial usefor non-medical and non-veterinary purposes; chemical preparations for use in the oil industry
Class 5
Pharmaceutical preparations for the treatment of diabetes and obesity; pharmaceutical preparations for haemostasis management and for the treatment of sickle cell disease; pharmaceutical preparations for the treatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney disease; pharmaceutical preparations for hormone therapy and stem cells for medical purposes; drug delivery devices containing pharmaceutical preparations for haemostasis managementpharmaceutical preparations for the treatment of sickle cell diseasebrain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasepharmaceutical preparations for hormone therapy and stem cells for medical purposes; chemical preparations for use in medical devicesdrug delivery agents consisting of compounds that deliver a wide range of pharmaceuticals
Class 9
downloadable electronic publicationsleafletsbooksbookletshandoutsmagazinesas well as medicalinstructional and teaching material in the field of diabetesobesityhaemostasis management and for the treatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment; downloadable electronic publications featuring electronic reports containing results from clinical trials and studies in the field of prevention and treatment of diabetesobesityhaemostasis management and for the treatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment; downloadable software applications for use with mobile devices for monitoring and management of medical data related to diabetesobesityhaemostasis management and for the treatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment; computer hardware and downloadable softwarefor use with medical injection devices for collectingtransmittingdisplaying medical data; downloadable medical software for the management of medical data related to diabetesobesityhaemostasis management and for the treatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment; downloadable software as a medical devicesoftware used in connection with medical devices to manage treatment of haemostasis management and for the treatment of sickle cell diseasebrain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cells for medical purposes
Class 10
Medical and surgical apparatus and instrumentshypodermic syringes and syringe pens; medical apparatus and instruments for reconstitution and injection of pharmaceutical preparations; medical apparatus and instrumentsinjection devices for administration of pharmaceutical preparationsmedical infusion pumps for delivering measured amounts of solutions into the bloodstream over timeinfusion pump controllersadhesive infusion devices for administering drugs; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with the management of diabetesobesityhaemostasis management and for the treatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment; medical and surgical apparatus and instrumentsinjection devices for the administration of pharmaceutical preparations and the wireless transmission of medical data in connection with the management of diabetesobesityhaemostasis management and for the treatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment; medical devicesautomatic needle insertion devicesprotection caps for hypodermic syringes and medical pens; needles for injections; cartridges and carpules for administration of pharmaceutical preparations
Class 41
Educational servicesorganizing and conducting educational programmescoaching and training services for patients and healthcare professionals related to management of diabetesobesityhaemostasis management and for the treatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment; arranging and conducting of educational conferencescongressesseminarssymposiums and workshops related to the management of diabetesobesityhaemostasis management and for the treatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment
Class 42
Providing scientific research information in the field of diabetesobesityhaemostasis managementtreatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment; providing temporary use of online non-downloadable software featuring technology that enables users to recordtrackgenerate reports regarding the conditiontreatment and the management of diabetesobesityhaemostasis management and for the treatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment
Class 44
Providing medical services via websites and mobile apps for the management of diabetesobesityhaemostasis management and for the treatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment; providing medical information and medical counselling featuring the management of diabetesobesityhaemostasis management and for the treatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment
Publications
History of USPTO decisions and trademark events.
34 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/15/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/27/2021
FIMP
FINAL DISPOSITION PROCESSED
07/27/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/13/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
04/13/2021
GPNX
NOTIFICATION PROCESSED BY IB
02/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/26/2021
PUBO
PUBLISHED FOR OPPOSITION
01/26/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/13/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/06/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/06/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/17/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/17/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/17/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
12/17/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/17/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
12/17/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/17/2020
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
12/09/2020
CRSN
CORRECTION SENT TO IB
11/18/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/11/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/11/2020
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
10/10/2020
RFNT
REFUSAL PROCESSED BY IB
09/27/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/06/2020
RFRR
REFUSAL PROCESSED BY MPU
09/02/2020
CRCR
CORRECTION CREATED FOR IB
09/01/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/30/2020
CNRT
NON-FINAL ACTION WRITTEN
07/29/2020
MAFR
APPLICATION FILING RECEIPT MAILED
07/28/2020
DOCK
ASSIGNED TO EXAMINER
07/24/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/24/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/23/2020
Continuous trademark protection
Get notified about every new filing that threatens NOVO NORDISK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.